Capital Brands Shareholders Approve Name Change to CompScript; Company Announces Outcome of Voting at Annual Meeting of Shareholders.

BOCA RATON, Fla.--(BUSINESS WIRE)--July 8, 1996--Capital Brands, Inc. (Nasdaq Small Cap: CAAS) today announced that at its Annual Meeting of Shareholders held on July 3, 1996, the Company's shareholders approved a change in the Company's name to CompScript, Inc. The Company's common stock will begin trading under its new Nasdaq symbol, CPRX, effective today.

The Company also announced that the following individuals were elected to serve on the Company's Board of Directors:

Brian A. Kahan, 44, has served as Chairman, Chief Executive Officer and President of the Company since April 1996. Mr. Kahan founded Aldencare, a provider of pharmaceuticals, infusion therapy, and management and consulting services in 1991 and served as its Chief Executive Officer until Aldencare's merger with CompScript in 1994.

Martha M. Little, 35, has served as Vice President and Director of the Company since April 1996. Ms. Little has been with Aldencare and CompScript since 1991, serving as Pharmacy Manager from 1991 until 1993. She was promoted to Vice President in 1992.

Gerard N. Altieri, 66, has been a Director of the Company since April 1996. Mr. Altieri formed CompScript, Inc. in 1993. From 1986 to 1993, Mr. Altieri was President of Insurx, a pharmacy benefit management company. From 1970 until 1990, Mr. Altieri was President of G.N. Altieri & Associates.

Malcolm Leonard, 53, has served as a Director of the Company since April 1996. Mr. Leonard is a Certified Public Accountant and has been the managing partner of Leonard & Danzinger, CPA's since 1975.

Robert Edelheit, 56, has served as a Director of the Company since April 1996. Mr. Edelheit is President of United Group Programs, an employee benefit sales and consulting firm.

Paul Heimberg, 45, has served as a Director of the Company since April 1996. Mr. Heimberg is a partner with the law firm of Heimberg & Lumer in Boca Raton, Florida.

Shareholders also voted in favor of increasing the authorized shares of common stock from 12,500,000 to 50,000,000, and to approve the Company's 1996 Stock Option Plan.

Brian A. Kahan, Chairman and Chief Executive Officer, commented, "The change in our Company's name is another important step in establishing our own identity as a comprehensive provider of pharmacy management services which lower costs and improve the quality of care. We are also very pleased to announce the election of these individuals to the Company's Board of Directors. Their insight and years of experience will continue to be a tremendous asset as we expand our industry presence."

CompScript, Inc. is a pharmaceutical health care company providing integrated services to the long-term care, sub-acute care, home care, mail order and pharmacy benefits management market. The Company has over 30,000 participating pharmacies in its nationwide pharmacy networks.

CONTACT: CompScript, Inc.

Brian A. Kahan, Chief Executive Officer

[phone]

-or-

INVESTOR RELATIONS COUNSEL:

The Equity Group Inc.

Devin Sullivan, [phone]

Robert Goldstein, [phone]